Skip to content

The effect of Gentamicin at cesarean section infection

The effect of using Gentamicin in subcutaneous tissue, before skin suturing at cesarean section infection

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200126046261N1
Enrollment
120
Registered
2020-05-14
Start date
2020-08-22
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound infection. Infection of obstetric surgical wound

Interventions

Intervention 1: Intervention group: The wounds of patients were irrigated with 100 cc normal saline plus 80 mg gentamicin (Exir Pharmaceutical Company) before closing the wound. Intervention 2: Contro

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Gestational age of early and full term Elective admission Having a live fetus Mother's mental health Pfannenstiel incision

Exclusion criteria

Exclusion criteria: Patients with known infection before surgery Having underlying diseases (diabetes, blood pressure, types of cancers) Patients with immune system deficiency Coagulation disorders Malnutrition Smoking and drug use People with a history of surgical wound infection in a previous cesarean section

Design outcomes

Primary

MeasureTime frame
Wound infection. Timepoint: The first day after surgery and the tenth and thirtieth day. Method of measurement: physical examination.;Wound dehiscence. Timepoint: The first day after surgery and the tenth and thirtieth day. Method of measurement: physical examination.

Secondary

MeasureTime frame
Pain in the operation area. Timepoint: The first day after surgery, the tenth day and the thirtieth day. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEbrahim nasirifar

Mazandaran University of Medical Sciences

enasiri@mazums.ac.ir+98 11 3354 3239

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026